...
首页> 外文期刊>Kidney international. >Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy
【24h】

Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy

机译:糖尿病性肾病的微血管病变和PAI-1增高

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy.BackgroundMicrovascular injury and mesangial dysfunction contribute to the pathogenesis of diabetic glomerulosclerosis. We investigated the extent of microvascular injury characterized by fragmented red blood cells (RBCs) in the mesangium of glomeruli in diabetic nephropathy, and its clinicopathologic significance. We also investigated the possible contributions of plasminogen activator inhibitor-1 (PAI-1), which has been implicated in thrombosis and sclerosis, and the novel steroid receptor superfamily member, peroxisome proliferator-activated receptor (PPAR), implicated in monocyte-foamy macrophage transformation in atherosclerosis and improved insulin responsiveness in diabetes.
机译:糖尿病肾病中的微血管病性损伤和PAI-1增高。背景微血管损伤和肾小球膜功能障碍是糖尿病性肾小球硬化的发病机理。我们调查了以糖尿病肾病肾小球系膜中的红细胞碎裂为特征的微血管损伤程度及其临床病理学意义。我们还研究了纤溶酶原激活物抑制剂1(PAI-1)的可能作用,它与血栓形成和硬化有关,新型类固醇受体超家族成员过氧化物酶体增殖物激活受体(PPAR)与单核细胞泡沫巨噬细胞有关。改变动脉粥样硬化并改善糖尿病的胰岛素反应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号